Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2013
10/16/2013CN102276592B Related substance of olanzapine and preparation method and analytical method thereof
10/16/2013CN102126963B Spirobifluorene amido compound and preparation method thereof
10/16/2013CN101679394B Oxime ester photoinitiators
10/16/2013CN101600706B Akt活性抑制剂 Akt activity inhibitor
10/15/2013US8558013 Electroluminescent materials
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8558006 Processes relating to the alkylation of pyrazoles
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013CA2767092C Novel compounds, pharmaceutical compositions containing same and methods of use for same
10/15/2013CA2623160C Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013151450A1 Aromatic imidazolidinone derivatives and their use in the treatment of diseases of bacterial nature
10/10/2013WO2013151297A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/10/2013WO2013150173A1 New alpha2 adrenoceptor agonists
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013US20130267543 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
10/10/2013US20130267538 Treatment of mitochondrial diseases
10/10/2013US20130267501 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
10/10/2013US20130267492 Aryl sulfonamides
10/09/2013EP2646434A1 Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof
10/09/2013CN103347860A Nampt抑制剂 Nampt inhibitor
10/09/2013CN103347859A Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
10/09/2013CN103342699A Coumarin-thiacalix [4] arene fluorescent reagent as well as preparation method and application thereof
10/09/2013CN103342674A Pyrrole derivatives with optical activity and synthetic method thereof
10/09/2013CN102516235B Dibenzothiophene chalcone containing coumarin skeleton and synthesis method and application thereof
10/09/2013CN102219725B Benzohetercyclic compound as well as preparation method and applications thereof
10/08/2013US8552039 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
10/08/2013US8552033 Inhibitors of CXCR2
10/08/2013US8552031 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
10/08/2013US8551988 Benzimidazole derivatives: preparation and pharmaceutical applications
10/08/2013US8551364 Process for inhibiting polymerization of an aromatic vinyl compound
10/08/2013CA2473938C Human adam-10 inhibitors
10/03/2013WO2013148857A1 Triazole derivatives as hsp90 inhibitors
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013147183A1 Triazinone compound and t-type calcium channel inhibitor
10/03/2013WO2013146963A1 Heterocyclic compound
10/03/2013WO2013146925A1 Non-linear optical material and non-linear optical element using same
10/03/2013WO2013144231A1 Herbicidal compounds
10/03/2013WO2013144224A1 Acetylenic microbiocides
10/03/2013WO2013144187A1 5-aminopyrimidine derivatives and use thereof for combating undesired plant growth
10/03/2013WO2013144129A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
10/03/2013WO2013144098A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
10/03/2013WO2013144097A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists
10/03/2013WO2013143597A1 Demethylase enzymes inhibitors
10/03/2013WO2013114403A8 Substituted 4,5-dihydro-2h-benzo[e]indazole-9-carboxylates for the treatment of diabetes and related disorders
10/03/2013US20130261314 Dyes and photoelectric conversion devices containing the same
10/03/2013US20130261155 1-(heterocyclic carbonyl) piperidines
10/03/2013US20130261135 Metalloenzyme inhibitor compounds
10/03/2013US20130261130 Neurotrypsin inhibitors
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/03/2013US20130259830 Crth2 modulators
10/02/2013EP2644605A1 Method for producing optically active fluorine-containing oxeten
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2644195A1 Immunosuppressant Compounds and Compositions
10/02/2013EP2643300A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013EP1944308B1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand
10/02/2013CN103339126A Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof
10/02/2013CN103339125A Pyrazole compounds as CRTH2 antagonists
10/02/2013CN103339123A Indeno- fused ring compounds having photochromic properties
10/02/2013CN103339118A Lactone compounds and materials made therefrom
10/02/2013CN103333170A 苯并咪唑类化合物及其用途 Benzimidazole compounds and their uses
10/02/2013CN103333164A Preparation method and application research of penthiopyrad analogue derivative
10/02/2013CN103333162A 病毒聚合酶抑制剂 Viral polymerase inhibitors
10/02/2013CN103333158A N-phenylcarbazole derivative and application thereof to electrophosphorescent device
10/02/2013CN103333097A Synthesis method of diindolylmethane derivatives
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8546581 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
10/01/2013US8546569 Chemical compounds
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013CA2710959C Imidazole carbonyl compounds and use thereof for treating bacterial infections
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
09/2013
09/26/2013WO2013142281A1 Inhibition of mcl-1 and/or bfl-1/a1
09/26/2013WO2013141057A1 Organic electroluminescence element
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130253024 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
09/26/2013US20130253008 Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof
09/26/2013US20130252979 Pharmaceutical compositions, dosage forms and new forms of the compound of mula (i), and methods of use thereof
09/26/2013US20130252964 Compounds And Methods For Treating Candidiasis And Aspergillus Infections
09/26/2013US20130252937 New indanyloxydihydrobenzofuranylacetic acids
09/26/2013US20130252934 Serine/threonine kinase inhibitors
09/25/2013EP2640806A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640721A2 Agonists that enhance binding of integrin-expressing cells to integrin receptors
09/25/2013EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
09/25/2013EP2640707A1 5-halogenopyrazolecarboxamides
09/25/2013EP2640706A1 N-aryl pyrazole(thio)carboxamides
09/25/2013EP2640704A1 Nampt inhibitors
09/25/2013EP2640191A1 5-halogenopyrazole(thio)carboxamides
09/25/2013CN103328533A Carboxylation of poly-/oligothiophenes
09/25/2013CN103328442A Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
09/25/2013CN103325950A Charge transport layers and films containing the same
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 523